BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21293934)

  • 21. TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population.
    Sameer AS; Shah ZA; Syeed N; Banday MZ; Bashir SM; Bhat BA; Siddiqi MA
    Genet Mol Res; 2010 Apr; 9(2):651-60. PubMed ID: 20449797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer.
    Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Nakatsu T; Saito H; Minamiya Y; Suzuki T; Ogawa J
    J Am Coll Surg; 2009 Oct; 209(4):477-83. PubMed ID: 19801321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein gene polymorphisms in biopsy-proven giant cell arteritis from Northwestern Spain.
    Palomino-Morales R; Vazquez-Rodriguez TR; Miranda-Filloy JA; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2009 Feb; 36(2):341-6. PubMed ID: 19040303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk.
    Knechtel G; Szkandera J; Stotz M; Hofmann G; Langsenlehner U; Krippl P; Samonigg H; Renner W; Langner C; Dehchamani D; Gerger A
    Mol Carcinog; 2010 Sep; 49(9):805-9. PubMed ID: 20572162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of XPC polymorphisms and tea drinking with colorectal cancer risk in a Chinese population.
    Wu Y; Jin M; Liu B; Liang X; Yu Y; Li Q; Ma X; Yao K; Chen K
    Mol Carcinog; 2011 Mar; 50(3):189-98. PubMed ID: 21104992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of COX2 -765G>C and c.3618A>G polymorphisms on the risk and survival of sporadic colorectal cancer.
    Iglesias D; Nejda N; Azcoita MM; Schwartz S; González-Aguilera JJ; Fernández-Peralta AM
    Cancer Causes Control; 2009 Oct; 20(8):1421-9. PubMed ID: 19468846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-reactive protein and the risk of cancer: a mendelian randomization study.
    Allin KH; Nordestgaard BG; Zacho J; Tybjaerg-Hansen A; Bojesen SE
    J Natl Cancer Inst; 2010 Feb; 102(3):202-6. PubMed ID: 20056955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
    Siemes C; Visser LE; Coebergh JW; Splinter TA; Witteman JC; Uitterlinden AG; Hofman A; Pols HA; Stricker BH
    J Clin Oncol; 2006 Nov; 24(33):5216-22. PubMed ID: 17114654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
    Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A
    Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-reactive protein gene C1444T polymorphism and risk of recurrent ischemic events in patients with symptomatic intracranial atherostenoses.
    Arenillas JF; Massot A; Alvarez-Sabín J; Fernandez-Cadenas I; del Rio-Espinola A; Chacon P; Quintana M; Molina CA; Rovira A; Montaner J
    Cerebrovasc Dis; 2009; 28(1):95-102. PubMed ID: 19494488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk.
    Liu B; Zhang Y; Jin M; Ni Q; Liang X; Ma X; Yao K; Li Q; Chen K
    Mol Carcinog; 2010 Jan; 49(1):75-84. PubMed ID: 19795398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of common CRP gene variants with CRP levels and cardiovascular events.
    Miller DT; Zee RY; Suk Danik J; Kozlowski P; Chasman DI; Lazarus R; Cook NR; Ridker PM; Kwiatkowski DJ
    Ann Hum Genet; 2005 Nov; 69(Pt 6):623-38. PubMed ID: 16266402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epistatic effect of C-reactive protein (CRP) single nucleotide polymorphism (SNP) +1059 and interleukin-1B SNP +3954 on CRP concentration in healthy male blood donors.
    Eklund C; Lehtimäki T; Hurme M
    Int J Immunogenet; 2005 Aug; 32(4):229-32. PubMed ID: 16026589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of polymorphisms within 5' and 3' untranslated regions of thymidylate synthase gene modulates survival in 5 fluorouracil-treated colorectal cancer patients.
    Fernández-Contreras ME; Sánchez-Hernández JJ; González E; Herráez B; Domínguez I; Lozano M; García De Paredes ML; Muñoz A; Gamallo C
    Int J Oncol; 2009 Jan; 34(1):219-29. PubMed ID: 19082493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression and single nucleotide polymorphisms of kallikrein 10 in colorectal cancer].
    Feng B; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Qu Y; Li JW; Lu AG; Wang ML; Liu BY; Zhu ZG
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):623-7. PubMed ID: 16784657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype.
    Abulí A; Bessa X; González JR; Ruiz-Ponte C; Cáceres A; Muñoz J; Gonzalo V; Balaguer F; Fernández-Rozadilla C; González D; de Castro L; Clofent J; Bujanda L; Cubiella J; Reñé JM; Morillas JD; Lanas A; Rigau J; García AM; Latorre M; Saló J; Fernández Bañares F; Argüello L; Peña E; Vilella A; Riestra S; Carreño R; Paya A; Alenda C; Xicola RM; Doyle BJ; Jover R; Llor X; Carracedo A; Castells A; Castellví-Bel S; Andreu M;
    Gastroenterology; 2010 Sep; 139(3):788-96, 796.e1-6. PubMed ID: 20638935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway.
    Reinertsen KV; Grenaker Alnæs GI; Landmark-Høyvik H; Loge JH; Wist E; Kristensen VN; Fosså SD; Edvardsen H
    Brain Behav Immun; 2011 Oct; 25(7):1376-83. PubMed ID: 21496483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer.
    Castro FA; Försti A; Buch S; Kalthoff H; Krauss C; Bauer M; Egberts J; Schniewind B; Broering DC; Schreiber S; Schmitt M; Hampe J; Hemminki K; Schafmayer C
    Eur J Cancer; 2011 May; 47(8):1203-10. PubMed ID: 21239167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-reactive protein (CRP) gene polymorphisms, CRP levels and risk of incident essential hypertension: findings from an observational cohort of Han Chinese.
    Kong H; Qian YS; Tang XF; Zhang J; Gao PJ; Zhang Y; Zhu DL
    Hypertens Res; 2012 Oct; 35(10):1019-23. PubMed ID: 22763479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.